Dynavox Group AB (publ) (DYVOX.ST)
Stockholm · SEK · Healthcare · Medical Instruments & Supplies
SEK 72.50 (+1.90%) as of
Key statistics
- Market cap
- 7.69B
- P/E (TTM)
- 28.10
- Forward P/E
- 34.52
- EPS (TTM)
- 2.58
- Dividend yield
- 0.70%
- 52-week range
- 57.20 – 106.90
- Beta
- 0.81
- Revenue (TTM)
- 2.62B
- Profit margin
- 10.53%
- Analyst target
- SEK 110.75
- Volume
- 225.93k
About Dynavox Group AB (publ)
Dynavox Group AB (publ), through its subsidiaries, engages in the development and sale of assistive technology products for customers with communication disabilities. The company offers custom designed augmentative and alternative communication (AAC) solutions that enable people with disabilities, such as cerebral palsy, ALS, autism, and spinal cord injury, to communicate on their own. Its communication solutions include language, software, hardware, funding, support, and training. The company operates in Sweden, Norway, Denmark, Belgium, the United States, Germany, France, China, the United Kingdom, Ireland, Australia, and New Zealand. The company was formerly known as Tobii Dynavox AB (publ) and changed its name to Dynavox Group AB (publ) in July 2024. Dynavox Group AB (publ) was incorporated in 2012 and is headquartered in Stockholm, Sweden.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Headquarters
- Stockholm, Sweden
- Employees
- 1,107
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.